← FDA Drug Approvals (Drugs@FDA)

DESVENLAFAXINE SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PLATINUM · Approved 2019-05-07

Drug application

FDA Application #
ANDA204805
Application type
Abbreviated New Drug Application (Generic)
Brand name
DESVENLAFAXINE SUCCINATE
Generic name
DESVENLAFAXINE
Active ingredients
DESVENLAFAXINE SUCCINATE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Marketing status
Prescription
Sponsor
PLATINUM
Manufacturer
Marlex Pharmaceuticals, Inc.
First approval
2019-05-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown